In July of 2018 a jury awarded a $4.69 billion verdict to a group of 22 women who proved that Talc Powder, produced by Johnson & Johnson, caused their ovarian cancer. This was the first time in a Talc trial that the plaintiffs maintained their ovarian cancer originated by exposure to asbestos contained in the talc powder. The attorneys for the women argued that, based on internal documents, Johnson & Johnson was aware that their product contained asbestos yet did nothing to warn users of the risks.
TALCUM POWDER AND ASBESTOS
Not all talc contains asbestos, but Talc and asbestos can often form together in the same geological setting, so talc can be contaminated by asbestos. Asbestos is a known carcinogen and is commonly linked to mesothelioma, a type of lung cancer. There are also scientific studies connecting asbestos to other forms of cancer such as ovarian cancer.
OVARIAN CANCER AND EXPOSURE TO J&J’S TALCUM POWDER
While there have been a host of ovarian cancer verdicts against Johnson & Johnson and their talc products, including Johnson’s Baby Powder™ and Shower to Shower™, this is the first successful verdict arguing that the ovarian cancer was caused by asbestos exposure. Previous plaintiffs have alleged that their ovarian cancer was due years of using talcum powder as part of their feminine hygiene routine. Their argument was based on studies asserting that talc particles, entering a woman’s body through the vagina, can inflame the pelvic area, and this inflammation can increase endometrial cancer risks. In October of 2017 there was also a $117 million verdict against J&J in a case claiming a woman’s mesothelioma was a result of her use of talcum powder. The July 2018 verdict was the first to link asbestos and ovarian cancer.
TALCUM POWDER ATTORNEY
Women who have used talcum powder for intimate personal hygiene may have unknowingly been put at risk of developing ovarian cancer. Please contact Brett H. Oppenheimer, PLLC who is seeking potential legal recourse for women who believe that talcum-based products contributed to their ovarian cancer and ovarian tumors. Email Brett using the form on this website, or you can call (502)242-8877 for a free consultation on your case.